Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease

…, T Okamoto, M Kobayashi, T Chiaki, T Yamashita… - Lung Cancer, 2021 - Elsevier
Objectives The efficacy of immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC)
patients with pre-existing interstitial lung disease (ILD) is unclear. Materials and …

Serum CEA and CYFRA levels in ALK-rearranged NSCLC patients: Correlation with distant metastasis

…, Y Funayama, S Hayashi, H Nakamura, T Yamashita - in vivo, 2020 - iv.iiarjournals.org
Aim: To clarify the correlation between serum levels of carcinoembryonic antigen (CEA) and
cytokeratin 19 fragment (CYFRA) and metastasis and survival in anaplastic lymphoma …

Acquired EGFR T790M mutation after relapse following EGFR-TKI therapy: a population-based multi-institutional study

…, K Furukawa, T Kodama, T Yamashita… - Anticancer …, 2018 - ar.iiarjournals.org
Aim: To describe the prevalence and determinants of acquired epidermal growth factor
receptor (EGFR) T790M gene mutation in a clinical practice setting. Materials and Methods: We …

The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial …

…, Y Jin, I Natsume, T Chiaki, T Yamashita… - International Journal of …, 2020 - Springer
Background Acute exacerbation (AE) of interstitial lung disease (ILD) is a fatal adverse event
in the treatment of lung cancer patients with ILD. The value of pre-treatment radiological …

Treatment of patients with non-small-cell lung cancer with uncommon EGFR mutations in clinical practice

…, H Nakamura, K Furukawa, T Yamashita… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: To describe real clinical outcomes in patients with non-small cell lung cancer
who have uncommon epidermal growth factor receptor (EGFR) mutations. Materials and …

Neurological symptoms of sarcoidosis-induced small fiber neuropathy effectively relieved with high-dose steroid pulse therapy

H Saito, T Yamaguchi, Y Adachi, T Yamashita… - Internal …, 2015 - jstage.jst.go.jp
A 59-year-old woman was admitted to our hospital for an evaluation of a 10-day history of
progressive pain and hypoesthesia of the right lower back associated with fever and …

[HTML][HTML] A glycosylphosphatidylinositol-anchored α-amylase encoded by amyD contributes to a decrease in the molecular mass of cell wall α-1, 3-glucan in …

K Miyazawa, T Yamashita, A Takeuchi… - Frontiers in Fungal …, 2022 - frontiersin.org
α-1,3-Glucan is one of the main polysaccharides in the cell wall of Aspergillus nidulans. We
previously revealed that it plays a role in hyphal aggregation in liquid culture, and that its …

Evaluation of the time-dependent changes and the vulnerability of carotid plaques using contrast-enhanced carotid ultrasonography

…, K Takano, H Abe, T Higashi, T Yamashita… - Journal of Stroke and …, 2018 - Elsevier
Background The association of carotid plaque enhancement on contrast-enhanced carotid
ultrasound (CEUS) and plaque vulnerability evaluated by magnetic resonance imaging (MRI) …

Novel strategy for protein production using a peptide tag derived from Bacillus thuringiensis Cry4Aa

…, S Sudo, Y Sakamoto, T Yamashita… - The FEBS …, 2010 - Wiley Online Library
Numerous proteins cannot be sufficiently prepared by ordinary recombinant DNA techniques
because they are unstable or have deleterious effects on the host cell. One idea to prepare …

Recurrent laryngeal nerve paralysis associated with endotracheal anesthesia

T YAMASHITA, Y HARADA, N UEDA… - Nippon Jibiinkoka …, 1965 - jstage.jst.go.jp
TAKAAKI YAMASHITA, YASUO HARADA, NAOAKI UEDA TAKASHI TASHIRO and
HIDEAKI KANEBAYASHI From the Department of Oto-rhino-laryngology, …